Examines competing pathways in the formation of cyclometalated platinum compounds, indicating their diverse applications in coordination chemistry.
X–C^N^N (X = Br, Cl) ligands were reacted with [Pt2Me4(μ-SMe2)2], 1, resulting in a six-coordinate cyclometalated platinum(IV) compound containing an anionic C^N^N ligand when X = Br and both a platinum(IV) and a platinum(II) product when X = Cl. The platinum(II) species was formed by C–H activation, followed by reductive elimination of methane. The platinum compounds were characterized by multinuclear NMR spectroscopy and single-crystal X-ray diffraction (SCXRD). Photophysical properties were explored by using UV/vis, emission, and transient absorption (TA) spectroscopies. DFT and TDDFT calculations were performed to examine the competition between C–H activation and C–X oxidative addition and compared to experimental results.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: